Table 2.
Advantages and drawbacks of CSF biomarkers.
| Advantages | Drawbacks |
|---|---|
| Diagnosis | Sampling |
| Prognosis | Standardization |
| Diagnostic cut-off values | |
| False positive – false negative rates | |
| Overlap with other dementias |
Advantages and drawbacks of CSF biomarkers.
| Advantages | Drawbacks |
|---|---|
| Diagnosis | Sampling |
| Prognosis | Standardization |
| Diagnostic cut-off values | |
| False positive – false negative rates | |
| Overlap with other dementias |